The Chinese Control Disease Center and the French Embassy in China held a Sino-French Medical Seminar on Diabetes in partnership with the Chinese Medical Association, French Healthcare, the French Diabetes Society and the French Healthcare Alliance in Beijing on June 29, 2019.
180 high level Chinese and French delegates (physicians, policymakers, hospital executives and journalists) participated in this event.
The event consisted in an institutional and medical seminar with presentations by 25 Chinese and French key opinion leaders focusing on recent developments and cross-disciplinary approaches to diabetes’ prevention, diagnostic, treatment, monitoring and complications management.
This event was supported by the French Healthcare Association and 6 companies of the French Healthcare Alliance (Axa, Air Liquide, Evolucare, Sanofi, Servier and Urgo).
